Prevention of Thrombosis by NO Secreting Polymers

通过分泌 NO 的聚合物预防血栓形成

基本信息

  • 批准号:
    8383118
  • 负责人:
  • 金额:
    $ 14.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-03 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this award is to develop an expert in blood/materials science. Why this project; why this candidate; and why this environment? Blood flows through the envelope of endothelium for a lifetime without clotting. When blood contacts anything but endothelium (collagen tissue, air, metal, plastic) it clots in a few seconds. This is normal physiology. Most of modern medicine depends on understanding these phenomena. We take advantage of it to allow all surgical procedures from venipuncture to transplantation. We try to prevent it when blood contacts medical devices from simple catheters to complex artificial organs. Better understanding of the physiology will result in better, safer blood contact devices which will impact all of medicine. For 100 years this research was focused on the components of the blood. Now it is focused on the endothelium. A blood/materials expert brings basic engineering and biologic science to the benefit of patients in every field of medicine. Dr. Hitesh Handa has the basic engineering knowledge. He also has the practical experience in development of blood contact devices. To this background he will add the chemistry of the endothelium, the biologic systems to evaluate materials, and experience in clinical application. In five years he will be on the small but vital roster of experts in blood/materials science. The combination of mentors, facilities and expertise at the University of Michigan provides an outstanding environment for Dr. Handa's development. Dr. Bartlett is a clinical surgeon and intensivist who has taken clinical problems to the biology laboratory for decades. Dr. Mark Meyerhoff is a basic scientist who has taken molecular chemistry to the biology laboratory for decades. Their combined research is focused on simulating the normal endothelium. Their students are among the experts in blood/materials science, from chemists and research biologists to industrial developers to clinical practitioners. .
描述(由申请人提供):该奖项的目标是培养血液/材料科学专家。为什么是这个项目;为什么是这个候选人;为什么是这个环境?血液在内皮细胞的包膜中流动而不凝结。当血液接触到内皮以外的任何东西(胶原组织、空气、金属、塑料)时,它会在几秒钟内凝结。这是正常的生理现象。大多数现代医学都依赖于对这些现象的理解。我们利用它来允许从静脉穿刺到移植的所有外科手术。当血液接触到从简单的导管到复杂的人造器官的医疗设备时,我们试图防止它。更好地了解生理学将导致更好、更安全的血液接触设备,这将影响所有医学。100年来,这项研究一直集中在血液的成分上。现在它的重点是内皮。血液/材料专家将基础工程和生物科学带给各个医学领域的患者。Hitesh Handa博士具有基本的工程知识。他还具有开发血液接触器械的实践经验。在此背景下,他将增加内皮的化学,生物系统,以评估材料,并在临床应用中的经验。五年后,他将成为血液/材料科学领域为数不多但至关重要的专家。密歇根大学的导师,设施和专业知识的结合为汉达博士的发展提供了出色的环境。Bartlett博士是一名临床外科医生和重症监护医生,数十年来一直将临床问题带到生物实验室。Mark Meyerhoff博士是一位基础科学家,几十年来一直将分子化学带到生物实验室。他们的联合研究集中在模拟正常内皮细胞。他们的学生是血液/材料科学方面的专家,从化学家和研究生物学家到工业开发人员再到临床医生。.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hitesh Handa其他文献

Hitesh Handa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hitesh Handa', 18)}}的其他基金

Metal organic framework-based antithrombotic surfaces
基于金属有机骨架的抗血栓表面
  • 批准号:
    10155583
  • 财政年份:
    2018
  • 资助金额:
    $ 14.79万
  • 项目类别:
Metal organic framework-based antithrombotic surfaces
基于金属有机骨架的抗血栓表面
  • 批准号:
    9922365
  • 财政年份:
    2018
  • 资助金额:
    $ 14.79万
  • 项目类别:
Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications
工程化一氧化氮释放聚合物与固定凝血酶抑制剂用于血液接触应用
  • 批准号:
    9883033
  • 财政年份:
    2017
  • 资助金额:
    $ 14.79万
  • 项目类别:
Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications
工程化一氧化氮释放聚合物与固定凝血酶抑制剂用于血液接触应用
  • 批准号:
    10545010
  • 财政年份:
    2017
  • 资助金额:
    $ 14.79万
  • 项目类别:
Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications
工程化一氧化氮释放聚合物与固定凝血酶抑制剂用于血液接触应用
  • 批准号:
    10367198
  • 财政年份:
    2017
  • 资助金额:
    $ 14.79万
  • 项目类别:
Prevention of Thrombosis by NO Secreting Polymers
通过分泌 NO 的聚合物预防血栓形成
  • 批准号:
    8522219
  • 财政年份:
    2012
  • 资助金额:
    $ 14.79万
  • 项目类别:
prevention of thrombosis by NO secreting polymer
NO分泌聚合物预防血栓形成
  • 批准号:
    9067509
  • 财政年份:
    2012
  • 资助金额:
    $ 14.79万
  • 项目类别:
Prevention of Thrombosis by NO Secreting Polymers
通过分泌 NO 的聚合物预防血栓形成
  • 批准号:
    8703168
  • 财政年份:
    2012
  • 资助金额:
    $ 14.79万
  • 项目类别:
Stent Coating to Prevent Restenosis and Subacute Thrombosis
支架涂层可预防再狭窄和亚急性血栓形成
  • 批准号:
    7682096
  • 财政年份:
    2008
  • 资助金额:
    $ 14.79万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 14.79万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了